About a year into the pandemic, some companies continue to use accounting cosmetics to add gloss to their financial results.

Finance chiefs in pursuit of mergers and acquisitions are facing high asking prices and strong competition from other dealmakers, leading some of them to seize the opportunity while others are holding off.

CFOs say the swings in the price of bitcoin could have negative effects on their balance sheets and question whether the practical uses of cryptocurrencies are worth the risk.

Eli Lilly & Co. said it won’t try to claw back past pay from newly departed finance chief Joshua Smiley, but moved to take away his 2020 bonus and other incentive compensation following years of rule tightening around executive conduct and recuperation of funds at the drugmaker.

Tackling operational issues such as procurement and corporate strategy likely helped Merck’s Chief Financial Officer Robert Davis acquire the skills needed for his promotion to the top spot.

McCormick’s finance chief is boosting the flavor company’s advertising spending to maintain growth in consumer sales as more people cook at home during the pandemic.

Mark Hawkins is handing over the reins of Salesforce’s finance function after helping lead the technology company through a period of relentless growth while displaying that often rare combination of methodical focus and people skills.

‘If I could raise money at $300 a share, I will do it in a heartbeat’: As retail investors pile into certain stocks, CarParts executives said it would be foolish not to take advantage of high stock market valuations and raise fresh capital.

The recent surge in some company stocks is providing CFOs with a sudden window of opportunity to tap new sources of funding. But not all of them are likely to cash in.

CFOs will have to wait and see if Brexit will lead to higher funding costs, as many British and European companies loaded up on liquidity before Dec. 31, potentially masking any immediate effects of the split.